logo
Share SHARE
FONT-SIZE Plus   Neg

HeartWare Intl. To Buy World Heart For $8 Mln

HeartWare International, Inc. (HTWR), which develops and manufactures miniaturized ventricular assist devices, said Thursday that it has agreed to buy World Heart Corp. (WHRT), which has been engaged in the development of left ventricular assist devices, for consideration of US$8 million, which will be paid in shares of HeartWare common stock or cash, at HeartWare's election.

The per share merger consideration will be determined by dividing $8 million by the number of shares of WorldHeart common stock outstanding on a fully diluted basis, or about $0.29 per share at today's fully diluted WorldHeart common stock outstanding.

The boards of directors of both companies have approved the deal, which is subject to the approval of WorldHeart's stockholders and satisfaction of other customary closing conditions. HeartWare stockholder approval is not required.

The deal is expected to close within about 90 days.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
The month of May saw the FDA greenlight 5 new drugs, including 1 new molecular entity, and surprisingly turn down 1 drug candidate, whose approval was considered a no-brainer by some experts. Lab equipment maker Thermo Fisher Scientific Inc. has agreed to acquire electron microscope maker FEI Co. for about $4.2 billion in cash, the two companies said Friday. Thermo Fisher noted that FEI's electron microscopy platform will complement its own mass spectrometry systems to accelerate advancements in structural biology. While reporting a wider loss for the first quarter, Sears Holdings Corp. said it has decided to "aggressively evaluate" all potential alternatives for its top brands - Kenmore, Craftsman and DieHard or KCD, and the Sears Home Services or SHS businesses. Sears has retained Citigroup Global Markets and LionTree Advisors to assist in its efforts.
comments powered by Disqus
Follow RTT